177 related articles for article (PubMed ID: 33336560)
1. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.
Liu Z; Li J; Li M; Chen S; Gao R; Zeng G; Chen D; Wang S; Li Q; Hu D; Zeng W; Guo L; Wu X
ESC Heart Fail; 2021 Feb; 8(1):644-651. PubMed ID: 33336560
[TBL] [Abstract][Full Text] [Related]
2. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
[No Abstract] [Full Text] [Related]
3. Features of α-HBDH in COVID-19 patients: A cohort study.
Zhu H; Qu G; Yu H; Huang G; Chen L; Zhang M; Wan S; Pei B
J Clin Lab Anal; 2021 Jan; 35(1):e23690. PubMed ID: 33372716
[TBL] [Abstract][Full Text] [Related]
4. Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
Ye J; Zheng L; Chen Z; Wang Q; Liao X; Wang X; Wei Q; Bao Y
BMC Urol; 2024 Mar; 24(1):62. PubMed ID: 38509518
[TBL] [Abstract][Full Text] [Related]
5. Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy.
Li X; He W; Zhang X; Shu F; Liu Y; Tan N; Jiang L
Front Cardiovasc Med; 2022; 9():995899. PubMed ID: 36204589
[TBL] [Abstract][Full Text] [Related]
6. Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression.
Zinellu A; Paliogiannis P; Carru C; Mangoni AA
Clin Exp Med; 2022 Nov; 22(4):499-508. PubMed ID: 34799779
[TBL] [Abstract][Full Text] [Related]
7. Serum hydroxybutyrate dehydrogenase as an early predictive marker of the severity of acute pancreatitis: a retrospective study.
Xiao W; Liu W; Yin L; Li Y; Lu G; Liu X; Gong W; Ding Y; Wang M; Yan Z
BMC Gastroenterol; 2020 Nov; 20(1):393. PubMed ID: 33218299
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of serum α-HBDH levels in patients with lung cancer.
Yuan ZM; Wang LH; Chen C
World J Surg Oncol; 2023 Mar; 21(1):78. PubMed ID: 36872314
[TBL] [Abstract][Full Text] [Related]
9. Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury.
Yu H; Han H; Li J; Li D; Jiang L
Int Immunopharmacol; 2019 Dec; 77():105922. PubMed ID: 31669891
[TBL] [Abstract][Full Text] [Related]
10. The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: A retrospective study.
Limin Z; Alsamani R; Jianwei W; Yijun S; Dan W; Yuehong S; Ziwei L; Huiwen X; Dongzhi W; Xingquan Z; Guojun Z
Front Neurol; 2022; 13():906249. PubMed ID: 36330431
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.
Yang Z; Hu Q; Huang F; Xiong S; Sun Y
Medicine (Baltimore); 2021 Aug; 100(32):e26900. PubMed ID: 34397917
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
Dong X; Sun L; Li Y
Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
[No Abstract] [Full Text] [Related]
13. α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting.
Lee S; Koppensteiner R; Kopp CW; Gremmel T
Sci Rep; 2019 Dec; 9(1):18200. PubMed ID: 31796860
[TBL] [Abstract][Full Text] [Related]
14. Serum lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase and ratio of alpha-hydroxybutyrate dehydrogenase to lactate dehydrogenase in testicular tumours.
Khanolkar MM; Sirsat AV; Deshmane VH; Kamat MR
Indian J Cancer; 1990 Dec; 27(4):243-9. PubMed ID: 1965310
[TBL] [Abstract][Full Text] [Related]
15. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
16. Implications of cardiac markers in risk-stratification and management for COVID-19 patients.
Li P; Wu W; Zhang T; Wang Z; Li J; Zhu M; Liang Y; You W; Li K; Ding R; Huang B; Wu L; Duan W; Han Y; Li X; Tang X; Wang X; Shen H; Wang Q; Yan H; Xia X; Ji Y; Chen H
Crit Care; 2021 Apr; 25(1):158. PubMed ID: 33902676
[TBL] [Abstract][Full Text] [Related]
17. Decreased CO
Hu D; Li J; Gao R; Wang S; Li Q; Chen S; Huang J; Huang Y; Li M; Long W; Liu Z; Guo L; Wu X
Front Public Health; 2020; 8():596168. PubMed ID: 33585382
[No Abstract] [Full Text] [Related]
18. Association Between Average Plasma Potassium Levels and 30-day Mortality During Hospitalization in Patients with COVID-19 in Wuhan, China.
Liu S; Zhang L; Weng H; Yang F; Jin H; Fan F; Zheng X; Yang H; Li H; Zhang Y; Li J
Int J Med Sci; 2021; 18(3):736-743. PubMed ID: 33437208
[No Abstract] [Full Text] [Related]
19. Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China.
Li L; Fang X; Cheng L; Wang P; Li S; Yu H; Zhang Y; Jiang N; Zeng T; Hou C; Zhou J; Li S; Pan Y; Li Y; Nie L; Li Y; Sun Q; Jia H; Li M; Cao G; Ma X
Aging (Albany NY); 2021 Feb; 13(3):3176-3189. PubMed ID: 33561834
[TBL] [Abstract][Full Text] [Related]
20. A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection.
Dong Y; Zhou H; Li M; Zhang Z; Guo W; Yu T; Gui Y; Wang Q; Zhao L; Luo S; Fan H; Hu D
Transbound Emerg Dis; 2020 Nov; 67(6):2823-2829. PubMed ID: 32469137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
